John Neis

Mr. John P.
Neis, CFA, is an Independent Director at Cellectar Biosciences, Inc., a Partner at Clarevia Ventures, an Advisory Board at University of Wisconsin Business School and a President & Director at Wisconsin Venture Capital Association.
He is on the Board of Directors at Delphinus Medical Technologies, Inc., Cellectar Biosciences, Inc., National Venture Capital Association, TAI Diagnostics, Inc., UpSkill LLC, Virent, Inc., Wisconsin Venture Capital Association and The Morgridge Institute for Research, Inc. Mr. Neis was previously employed as an Independent Director by Novelos Therapeutics, Inc. He also served on the board at Mithridion, Inc., Cellectar, Inc., TomoTherapy, Inc., Deltanoid Pharmaceuticals, Inc., Inviragen, Inc., NimbleGen Systems, Inc., Prevacept Infection Control, Inc., Third Wave Technologies, Inc., Wisconsin Growth Capital Coalition and Wisconsin Technology Council.
He received his undergraduate degree from the University of Utah and a graduate degree from the University of Wisconsin.